Connect with us


FDA authorizes Covid boosters for teens 12-15



FDA authorizes Covid boosters for teens 12-15

These decisions were made because the Omicron variant is more transmissible and could disrupt daily life throughout the country. In addition, school districts in Democratic-led States have reduced efforts to make sure students are vaccinated so they don’t get ahead of regulators.

“Throughout the pandemic, as the virus that causes Covid-19 has continuously evolved, the need for the FDA to quickly adapt has meant using the best available science to make informed decisions with the health and safety of the American public in mind,”Acting FDAJanet Woodcock, Commissioner, stated in a statement. “With the current wave of the omicron variant, it’s critical that we continue to take effective, life-saving preventative measures such as primary vaccination and boostersCOVID-19 can be effectively fought by social distancing and mask wearing

“In the current situation, it is important to offer all eligible individuals a booster, particularly against the backdrop of the newly-emerging variants such as Omicron,” Ugur Sahin, CEO and co-founder of BioNTech said in a statement.

The Centers forExpected to review expanded eligibility by the Disease Control and Prevention advisory panel on vaccines forThe boostersThis week, before you decide whether to recommend the shots forThe youngest teensAccording to news reports,

The FDAOn Dec. 9, the CDC extended booster access to 16 and 17-year olds, citing Omicron’s rapid growth.

The protection of teenagers may be increased by boosting them when they return in January to school. CovidThe coronavirus is more easily spread in winter when Americans are forced to stay indoors due to the cold weather. Omicron has spread throughout the country, convincing experts to accept it as a boosting strategy. This is because the healthcare systems across the nation are stretched to their limit.

Some medical experts have warned against the use of additional messenger RNA vaccines in order to protect young, healthy patients from myocarditis. This is an inflammatory condition that can lead to heart disease and can be fatal. forChildren with little safety data. The most vulnerable are teens and young adults, particularly those under 30 years old, who are especially at high risk for developing the condition.